Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

The objective of this study was to assess whether adding CAN-2409 in combination with the prodrug valacyclovir to standard of ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced longer-term follow-up results from an open-label extension of the Phase 3 ARCHES ...

The latest data from studies across Bayer’s oncology and women’s health portfolios will be presented at the upcoming 2025 ...

The 82-year-old's office said he visited his doctor after experiencing urinary symptoms that ultimately led to his advanced cancer diagnosis.

SimpliSafeEarly on, SimpliSafe established itself as the best DIY, self-monitored home security option on the market. Not ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 American Society of ...

It seems like you have to sign up for professional ... So when I went into ADT's app, it showed me the same thing YouTube did. The only problem is the door thing. I had to put a box under it ...

Former President Joe Biden has been diagnosed with aggressive prostate cancer following urinary symptoms. Here's all you need ...

The former U.S. President’s personal office announced on Sunday that he had been diagnosed with an “aggressive form” of ...